| 1. |
- Kashani, Hossein, et al.
(författare)
-
Implant Rehabilitation of Alveolar Ridge Defects (Chapter 14)
- 2020
-
Ingår i: Advanced Oral and Maxillofacial Implatology. Mohammad Hosein Kalantar Motamedi (Editor). - New York : Nova Science Publishers Inc. - 9781536169317
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)
|
|
| 2. |
- Hägglöf, Bruno
(författare)
-
Neuropsykiatriska funktionshinder hos barn
- 2020. - 5
-
Ingår i: Barnmedicin. - Lund : Studentlitteratur AB. - 9789144129563 ; , s. 637-674
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)
|
|
| 3. |
|
|
| 4. |
- Pergert, Pernilla, et al.
(författare)
-
Intercultural competence and communication over language barriers
- 2020
-
Ingår i: Ethical issues in pediatric hematology/oncology. - Cham : Springer. - 9783030226831 - 9783030226848 ; , s. 203-222
-
Bokkapitel (refereegranskat)abstract
- Intercultural healthcare refers to when people of different cultures and languages communicate and interact in the healthcare context. Intercultural competence is pivotal to provide congruent and meaningful care. The notion intercultural stresses that at least two cultures are involved; however, many use the term cultural. Cultural competence has been described as a process in healthcare interactions and systems, aiming to increase equity and reduce disparities in care. Cultural competence shares core components with patient centered care, but patient centered care is difficult when the values of patients are in conflict with the values of the healthcare professionals and systems. Cultural diversity can lead to conflicts of the most fundamental values and thus, intercultural healthcare requires that professionals have opportunities and skills to deal with value conflicts. We present a relational ethics approach for intercultural competence. The basic ideas of relational ethics, and of intercultural competence, are that they exist in relationships, the context is of importance and true dialogue is the core. The components of intercultural competence are explained and include intercultural dialogue, intercultural reflection and intercultural learning. Furthermore, intercultural communication, i.e. the act of communicating between distinct cultural groups, is pivotal to enable intercultural dialogue and should continuously be developed through intercultural learning in the process of understanding and adapting to the other. We will also discuss professional interpreters’ impact on cultural learning and mutual understanding in the intercultural healthcare context. We argue that healthcare professionals need to learn effective interpreting use as part of intercultural competence.
|
|
| 5. |
- Solheim, Ole, et al.
(författare)
-
Quality of life outcomes in meningioma surgery.
- 2020
-
Ingår i: Handbook of clinical neurology. Vol. 170. - : Elsevier. - 0072-9752. ; , s. 311-321
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)abstract
- Patient-reported quality of life measures hold the potential to capture the results of meningioma surgery in a more patient-centered and sensitive way than common morbidity measures. However, quality of life measures have not so far been used much in meningioma studies. Disease specific instruments are also lacking along with validation studies in patients with meningioma. While patient-reported quality of life measures may overestimate improvements and underestimate surgery-related deteriorations, quality of life studies still report worse outcomes than the common retrospective review of hospital records. A more widespread use of longitudinal assessment of quality of life would also have the benefit in moving meningioma research from retrospective to prospective, which would lead to superior data quality. Comparisons across studies would also be more valid as the assessment bias resulting from surgeons judging their own results would be avoided.
|
|
| 6. |
- Zhang, Wei, et al.
(författare)
-
Surgical treatment of low-grade brain tumors associated with epilepsy
- 2020
-
Ingår i: NOVEL THERAPEUTIC ADVANCES IN GLIOBLASTOMA. - LONDON ENGLAND : Elsevier. - 9780128211144 ; , s. 171-183
-
Bokkapitel (refereegranskat)abstract
- Objective: To explore the strategy of surgical treatment of low-grade brain tumors associated with epilepsy. Methods: Clinical data of 158 patients with low-grade brain tumors were collected from January 2011 to December 2017 in Guangdong Sanjiu brain hospital. All patients received Preoperative evaluation. Lesion site: 18 cases were located in multiple cerebral lobes, 10 cases were in the functional zones, 130 cases were in the non-functional zones (including 74 cases were in the medial of temporal lobe). The surgical strategy included subtotal resection, gross-total resection and enlarged resection. Postoperative effects were evaluated by Engel classification. Results: A total of 158 patients underwent surgical treatment, among these patients, only 1 patient underwent intracranial electrode implantation. Surgical methods: 34 cases of subtotal resection, 3 cases of gross-total resection, 119 cases of enlarged resection (including Anterior temporal lobectomy in 74 cases) and 2 case of Selective hippocampal amygdalectomy. The final pathology suggested that there are 74 cases of ganglionglioma, 25 cases of dysembryoplastic neuroepithelial tumors, 9 cases of pilocytic astrocytoma, 16 cases of oligodendroglioma, 10 cases of pleomorphic xanthoastrocytoma, 4 case of diffuse astrocytoma, 9 cases of unclassified astrocytoma, 11 case of oligoastrocytoma. The follow-up time was between 1 and 7 years, with an average of 3.44 +/- 1.77 years. Postoperative recovery: 147 patients had an Engel Class I outcome, 10 patients were in Engel Class II, 1 patient was in Class IV. Conclusion: The strategy of surgical treatment of low-grade brain tumors associated with epilepsy should pay more attention to the preoperative assessment of the epileptogenic zone. The tumor is not exactly the same as the epileptogenic zone, and the strategy of surgical treatment depends on the tumor feature as well as whether it was located in temporal lobe or involved in functional areas.
|
|
| 7. |
- Lindmark, Ulrika, 1965-
(författare)
-
Munhälsa hos äldre
- 2020. - 3
-
Ingår i: Äldre och åldrande: grundbok i gerontologi<em> </em>. - Malmö : Gleerups Utbildning AB. - 9789151102689 ; , s. 111-120
-
Bokkapitel (populärvet., debatt m.m.)
|
|
| 8. |
- Berggren, Diana, et al.
(författare)
-
Öron-, näs- och halssjukdomar hos barn
- 2020. - 5
-
Ingår i: Barnmedicin. - Lund : Studentlitteratur AB. - 9789144129563 ; , s. 881-887
-
Bokkapitel (övrigt vetenskapligt/konstnärligt)
|
|
| 9. |
- Li, Cong, et al.
(författare)
-
The therapeutic and neuroprotective effects of an antiepileptic drug valproic acid in glioma patients
- 2020
-
Ingår i: Neuropharmacology of Neuroprotection. - : ELSEVIER. - 9780128208137 ; , s. 369-379
-
Bokkapitel (refereegranskat)abstract
- Glioma is the most common primary malignant brain tumor in adults and the patients have poor prognosis despite treatment with surgery, radiotherapy and chemotherapy. The anti-epileptic drug, valproic acid (VPA) as a HDAC inhibitors is often used in glioma patients even if the patients don't have brain tumors associated epilepsy (BAE). Some previous studies have found that VPA not only has anti-epileptic effect, but also has anti-glioma growth effect through enhance radiotherapy sensitivity or other mechanism. Then VPA is reported to improve the survival of glioma patients receiving chemoradiation therapy. In addition, there are limited researches have shown that VPA has a neuroprotective effect in protect normal cells and tissues from the deleterious effects of treatment of glioma, especially radiotherapy. We'll give a brief overview of these effects of VPA in glioma patients.
|
|
| 10. |
- Sharma, Hari Shanker, et al.
(författare)
-
Pathophysiology of blood-brain barrier in brain tumor. : Novel therapeutic advances using nanomedicine
- 2020
-
Ingår i: Novel Therapeutic Advances In Glioblastoma. - LONDON ENGLAND : Elsevier. - 9780128211144 ; , s. 1-66
-
Bokkapitel (refereegranskat)abstract
- Glioblastoma Multiforme (GBM) is one the most common intracranial tumors discovered by Burns (1800) and Abernethy (1804) based on gross morphology of the autopsied material and referred to as "medullary sarcoma" and later "fungus medullare" (Abernethy, 1804; Burns, 1800). Virchow in 1863 was the first German pathologist using histomorphological techniques discovered that GBM is a tumor of glial origin. Virchow (1863/65) also then used the term Glioma for the first time and classified as low-grade glioma and high-grade glioma very similar to that of today according to World health organization (WHO) classification (Jellinger, 1978; Virchow, 1863/65). After almost >50 years of this discovery, Baily and Cushing (1926) based on modern neuropathological tools provide the classification of gliomas that is still valid today (Baily & Cushing, 1926). Although, our knowledge about development of gliomas has advanced through development of modern cellular and molecular biological tools (Gately, McLachlan, Dowling, & Philip, 2017; Omuro & DeAngelis, 2013), therapeutic advancement of GBM still requires lot of efforts for the benefit of patients. This review summarizes new developments on pathophysiological aspects of GBM and novel therapeutic strategies to enhance quality of life of patients. These novel therapeutic approaches rely on enhanced penetration of drug therapy into the tumor tissues by use of nanomedicine for both the diagnostic and therapeutic purposes, referred to as "theranostic nanomedicine" (Alphandery, 2020; Zhao, van Straten, Broekman, Preat, & Schiffelers, 2020). Although, the blood-brain barrier (BBB) is fenestrated around the periphery of the tumor tissues, the BBB is still tight within the deeper tissues of the tumor. Thus, drug delivery is a challenge for gliomas and requires new therapeutic advances (Zhao et al., 2020). Associated edema development around tumor tissues is another factor hindering therapeutic effects (Liu, Mei, & Lin, 2013). These factors are discussed in details using novel therapeutic advances in gliomas.
|
|
